/Zimmer%20Biomet%20Holdings%20Inc%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
With a market cap of $18 billion, Indiana-based Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology company specializing in musculoskeletal healthcare. Founded in 1927, it focuses on the design and manufacture of orthopedic products for bones, joints, and supporting tissues.
The company is slated to announce its fiscal Q1 2026 results before the market opens on Monday, May 4. Ahead of the event, analysts expect Zimmer Biomet to report an adjusted EPS of $1.86, up 2.8% from $1.81 in the year-ago quarter. It has surpassed Wall Street's bottom-line estimates in each of the past four quarterly reports, which is admirable.